These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10890792)

  • 1. Livial: an economic appraisal.
    Phillips CJ
    Br J Obstet Gynaecol; 1999 Mar; 106 Suppl 19():22-8. PubMed ID: 10890792
    [No Abstract]   [Full Text] [Related]  

  • 2. Tibolone. KB 889, ORG OD 14, ORG OD14, Livial, Livifem, Boltin.
    Drugs R D; 1999 Mar; 1(3):225-7. PubMed ID: 10566032
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livial: a review of clinical studies.
    Moore RA
    Br J Obstet Gynaecol; 1999 Mar; 106 Suppl 19():1-21. PubMed ID: 10890791
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of continuous combined hormone replacement therapy in long-term use: economic evaluation based on a 9-year study in Finland.
    Ylikangas S; Bäckström T; Heikkinen J
    Curr Med Res Opin; 2007 Jan; 23(1):57-64. PubMed ID: 17257466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The concept of selective action steroids].
    Jamin C
    Gynecol Obstet Fertil; 2000 Dec; 28(12):931-9. PubMed ID: 11192203
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience in the treatment of climacteric complaints with Livial (Organon)].
    Pekhlivanov B; Malinova M; Milchev N
    Akush Ginekol (Sofiia); 2001; 40(4):16-7. PubMed ID: 11803863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation on the compliance of livial therapy in peri and postmenopausal women].
    Bai W; Yang X; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):219-21. PubMed ID: 11776164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate.
    Mobley LR; Hoerger TJ; Wittenborn JS; Galuska DA; Rao JK
    Med Decis Making; 2006; 26(2):194-206. PubMed ID: 16525173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial.
    Zethraeus N; Borgström F; Jönsson B; Kanis J
    Int J Technol Assess Health Care; 2005; 21(4):433-41. PubMed ID: 16262965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysterectomy--a life-saving as well as a life-enhancing operation?
    Studd J
    Menopause Int; 2009 Mar; 15(1):2-3. PubMed ID: 19237613
    [No Abstract]   [Full Text] [Related]  

  • 13. Tibolone: new type of hormone replacement.
    Harv Womens Health Watch; 2001 Dec; 9(5):5. PubMed ID: 11751099
    [No Abstract]   [Full Text] [Related]  

  • 14. Tibolone and its effects on bone: a review.
    Berning B; Bennink HJ; Fauser BC
    Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic appraisal of the Boston Ocular Surface Prosthesis.
    Shepard DS; Razavi M; Stason WB; Jacobs DS; Suaya JA; Cohen M; Rosenthal P
    Am J Ophthalmol; 2009 Dec; 148(6):860-8.e2. PubMed ID: 19781684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of hormone therapy in younger and older postmenopausal women.
    Salpeter SR; Buckley NS; Liu H; Salpeter EE
    Am J Med; 2009 Jan; 122(1):42-52.e2. PubMed ID: 19114171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in lipidic and hemostatic parameters induced by tibolone treatment.
    Rosati D; Micheli S; Pinto S; Fedi S; Bruni V; Bucciantini S; Cellai AP; Liotta AA; Prisco D; Stefanelli F; Abbate R
    Thromb Res; 1997 Feb; 85(3):273-8. PubMed ID: 9058502
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impacts of sex hormones on histomorphometric and histological appearances of bone in ovariectomized rats].
    Yong H; Cheng Y
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):90-3. PubMed ID: 11263205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement in older men and women.
    Morley JE
    J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.